Presentation TCT 2012 TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study Presenter: Paul Gurbel October 23, 2012
Presentation TCT 2012 Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety Presenter: Ajay Kirtane October 23, 2012
Presentation TCT 2012 TCT-28. Is the Rate of Femoral Access Site Complications Increased in the Hands of 'Radialists'? Presenter: Stefano Rigattieri October 23, 2012
Presentation TCT 2012 Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR Presenter: Hendrik Treede October 23, 2012
Presentation TCT 2012 Pathogenesis of Vulnerable Plaque 2012: What's New? Presenter: Renu Virmani October 23, 2012
Presentation TCT 2012 TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with... Presenter: Michel Corban October 23, 2012
Presentation TCT 2012 TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting... Presenter: Clemens von Birgelen October 23, 2012
Presentation TCT 2012 Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For Presenter: Horst Sievert October 23, 2012
Presentation TCT 2012 Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con! Presenter: Andrej Schmidt October 23, 2012